We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Neurocrine Biosciences Inc | NASDAQ:NBIX | NASDAQ | Common Stock |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
125.00 | 139.01 | 137.27 | 133.57 | 136.55 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.89B | 249.7M | 2.5094 | 53.96 | 13.47B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
22:04:20 | formt | 21,201 | 135.41 | USD |
Date | Time | Source | Headline |
---|---|---|---|
05/12/2023 | 21:53 | DJN | Neurocrine Biosciences Gets FDA Breakthrough Therapy Status for Genetic.. |
18/8/2023 | 22:33 | DJN | Neurocrine Biosciences' Ingrezza Gets FDA Approval |
Neurocrine Biosciences (NBIX) Share Charts1 Year Neurocrine Biosciences Chart |
|
1 Month Neurocrine Biosciences Chart |
Intraday Neurocrine Biosciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions